Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stockert (now LivaNova Deutschland GmbH) is a world-leading manufacturer of cardiopulmonary bypass technology and medical devices for cardiac surgery. Based in Munich, Germany, the company is best known for its heart-lung machines, including the industry-standard S3 and S5 systems, which provide extracorporeal circulation during complex surgical procedures. Their product line also encompasses centrifugal pumps, heater-cooler units for patient temperature management, and advanced perfusion data management software. Following its acquisition by the Sorin Group and the subsequent merger into LivaNova, the Stockert brand remains a cornerstone of the global cardiac surgery market. The company continues to innovate with the recent launch of the Essenz Perfusion System, integrating digital health solutions with clinical hardware.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stockert.